Home
VRNA
VRNA News

Latest Verona Pharma plc (VRNA) News on February 22, 2025

Verona Pharma Announces March 2025 Investor Conference Participation

GlobeNewswire

4 days ago

Verona Pharma Announces March 2025 Investor Conference Participation

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

GlobeNewswire

9 days ago

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'

Zacks

10 days ago

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA)

Zacks

a month ago

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA)

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Insider Monkey

a month ago

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Investor's Business Daily

a month ago

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?

Zacks

a month ago

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a month ago

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

a month ago

Roth Initiates Verona Pharma at Buy

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long

Simply Wall St.

a month ago

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

a month ago

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable

MT Newswires

a month ago

Verona Pharma to Report $36 Million in Q4 Net Product Revenue

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

GlobeNewswire

a month ago

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

MT Newswires

3 months ago

Verona Pharma Insider Sold Shares Worth $1,176,360, According to a Recent SEC Filing

Verona Pharma Announces December 2024 Investor Conference Participation

GlobeNewswire

3 months ago

Verona Pharma Announces December 2024 Investor Conference Participation

MT Newswires

4 months ago

Verona Pharma Insider Sold Shares Worth $568,387, According to a Recent SEC Filing

MT Newswires

4 months ago

Verona Pharma Insider Sold Shares Worth $618,658, According to a Recent SEC Filing

Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years

Simply Wall St.

4 months ago

Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs

GuruFocus.com

4 months ago

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs

Verona Pharma to Present at Jefferies London Healthcare Conference

GlobeNewswire

4 months ago

Verona Pharma to Present at Jefferies London Healthcare Conference

MT Newswires

4 months ago

Verona Pharma's Q3 Loss Widens

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

4 months ago

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma PLC (VRNA) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

4 months ago

Verona Pharma PLC (VRNA) Q3 2024 Earnings Report Preview: What To Expect

Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why

Zacks

4 months ago

Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

Zacks

4 months ago

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

Zacks

4 months ago

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

MT Newswires

4 months ago

Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing

MT Newswires

4 months ago

Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

4 months ago

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet

Zacks

4 months ago

Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

4 months ago

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why

MT Newswires

5 months ago

Wells Fargo Initiates Verona Pharma at Overweight With $50 Price Target

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

GlobeNewswire

5 months ago

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)

GuruFocus.com

5 months ago

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

GuruFocus.com

5 months ago

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

GlobeNewswire

6 months ago

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)

GuruFocus.com

6 months ago

Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)

Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?

Insider Monkey

6 months ago

Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?

MT Newswires

6 months ago

Verona Pharma Q2 Net Loss Widens

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability

Simply Wall St.

7 months ago

Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

GlobeNewswire

7 months ago

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

7 months ago

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

MT Newswires

7 months ago

Canaccord Genuity Raises Verona Pharma's Price Target to $37 From $35, Maintains Buy Rating

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why

Zacks

7 months ago

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why

MT Newswires

8 months ago

Truist Securities Raises Price Target on Verona Pharma to $38 From $32, Maintains Buy Rating

Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy

Pharmaceutical Technology

8 months ago

Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

Benzinga

8 months ago

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

Pharmaceutical Technology

8 months ago

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

MT Newswires

8 months ago

HC Wainwright Adjusts Price Target on Verona Pharma to $36 From $32, Maintains Buy Rating

MT Newswires

8 months ago

Update: Verona Pharma Gets FDA Nod for Pulmonary Disease Treatment; Shares Jump Premarket

MT Newswires

8 months ago

Verona Pharma Gets US FDA Approval for Ohtuvayre in Chronic Obstructive Pulmonary Disease

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

GlobeNewswire

8 months ago

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

Investor's Business Daily

8 months ago

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

8 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

8 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

8 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

8 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

8 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

8 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

8 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

8 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024

Pharmaceutical Technology

9 months ago

Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024

GuruFocus.com

9 months ago

Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview

Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript

MT Newswires

9 months ago

Verona Pharma Signs Financing Agreements for Up to $650 Million

MT Newswires

9 months ago

Verona Pharma Shares Decline After Q1 Loss Widens

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

9 months ago

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS

GlobeNewswire

9 months ago

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024

GlobeNewswire

10 months ago

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024

Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

10 months ago

Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update

Andrew Fisher Joins Verona Pharma as General Counsel

GlobeNewswire

a year ago

Andrew Fisher Joins Verona Pharma as General Counsel

Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript

3 Healthcare Stocks That Have Outperformed Nvidia Since 2022

Motley Fool

a year ago

3 Healthcare Stocks That Have Outperformed Nvidia Since 2022

GuruFocus.com

a year ago

Verona Pharma PLC Reports Fourth Quarter and Full Year 2023 Financial Results

Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

When Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?

Simply Wall St.

a year ago

When Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?

Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

GlobeNewswire

a year ago

Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Sylvamo Corporation (SLVM) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks

a year ago

Sylvamo Corporation (SLVM) Upgraded to Strong Buy: What Does It Mean for the Stock?

Michael Austwick Joins Verona Pharma as Non-Executive Director

GlobeNewswire

a year ago

Michael Austwick Joins Verona Pharma as Non-Executive Director

Best Momentum Stocks to Buy for January 26th

Zacks

a year ago

Best Momentum Stocks to Buy for January 26th

Earnings Preview: Hub Group (HUBG) Q4 Earnings Expected to Decline

Zacks

a year ago

Earnings Preview: Hub Group (HUBG) Q4 Earnings Expected to Decline

OFG Bancorp (NYSE:OFG) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

OFG Bancorp (NYSE:OFG) Q4 2023 Earnings Call Transcript

A Look At The Fair Value Of Formula One Group (NASDAQ:FWON.K)

Simply Wall St.

a year ago

A Look At The Fair Value Of Formula One Group (NASDAQ:FWON.K)

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade

Zacks

a year ago

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade

Northern Trust Celebrates Dr. Martin Luther King, Jr. by Giving Back

ACCESSWIRE

a year ago

Northern Trust Celebrates Dr. Martin Luther King, Jr. by Giving Back

Q3 Rundown: Bentley (NASDAQ:BSY) Vs Other Vertical Software Stocks

StockStory

a year ago

Q3 Rundown: Bentley (NASDAQ:BSY) Vs Other Vertical Software Stocks

Infinitum and Alliance Resource Partners, L.P. Announce Agreement to Bring Highly Efficient, Reliable Motor Technology to the Mining Industry

Business Wire

a year ago

Infinitum and Alliance Resource Partners, L.P. Announce Agreement to Bring Highly Efficient, Reliable Motor Technology to the Mining Industry

Verona Pharma plc's (NASDAQ:VRNA) latest 11% decline adds to one-year losses, institutional investors may consider drastic measures

Simply Wall St.

a year ago

Verona Pharma plc's (NASDAQ:VRNA) latest 11% decline adds to one-year losses, institutional investors may consider drastic measures

Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance

Zacks

a year ago

Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance

Next-Gen Wealth: 7 Stocks to Catapult You to Millionaire Status

InvestorPlace

a year ago

Next-Gen Wealth: 7 Stocks to Catapult You to Millionaire Status

Thoughtworks Looking Glass Report Spotlights Strategy, Security and Responsibility in AI Solutions

Business Wire

a year ago

Thoughtworks Looking Glass Report Spotlights Strategy, Security and Responsibility in AI Solutions

3 Stocks Set to Soar 68% to 200% Higher

InvestorPlace

a year ago

3 Stocks Set to Soar 68% to 200% Higher

Here’s How Viasat (VSAT) Rebounded From “Stupidly Cheap” Levels

Insider Monkey

a year ago

Here’s How Viasat (VSAT) Rebounded From “Stupidly Cheap” Levels

Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) stock falls 7.4% in past week as three-year earnings and shareholder returns continue downward trend

Simply Wall St.

a year ago

Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) stock falls 7.4% in past week as three-year earnings and shareholder returns continue downward trend

Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference

Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital

GlobeNewswire

a year ago

Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital

3 Stocks That Could Be Monster Winners in 2024

Motley Fool

a year ago

3 Stocks That Could Be Monster Winners in 2024

Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day

Zacks

a year ago

Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024

Zacks

a year ago

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024

Share on Social Networks: